Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges von Hussen, Bashdar Mahmud, Rasul, Mohammed Fatih, Abdullah, Snur Rasool, Hidayat, Hazha Jamal, Faraj, Goran Sedeeq Hama, Ali, Fattma Abodi, Salihi, Abbas, Baniahmad, Aria, Ghafouri-Fard, Soudeh, Rahman, Milladur, Glassy, Mark C, Branicki, Wojciech, Taheri, Mohammad

Volltext

The interaction between miRNAs/lncRNAs and Notch pathway in human disorders von Ghafouri-Fard, Soudeh, Glassy, Mark C., Abak, Atefe, Hussen, Bashdar Mahmud, Niazi, Vahid, Taheri, Mohammad

Volltext

A comprehensive overview of identified mutations in SARS CoV-2 spike glycoprotein among Iranian patients von Eslami, Solat, Glassy, Mark C., Ghafouri-Fard, Soudeh

Volltext

A Binding Potency Assay for Pritumumab and Ecto-Domain Vimentin von Babic, Ivan, Kesari, Santosh, Glassy, Mark C.

Volltext

Novel Ganglioside Antigen Identified by B Cells in Human Medullary Breast Carcinomas: The Proof of Principle Concerning the Tumor-Infiltrating B Lymphocytes von Kotlan, Beatrix, Simsa, Peter, Teillaud, Jean-Luc, Fridman, Wolf Herman, Toth, Jozsef, McKnight, Michael, Glassy, Mark C

Volltext

Hepatocellular carcinoma up-regulated long non-coding RNA: a putative marker in multiple sclerosis von Sayad, Arezou, Taheri, Mohammad, Arsang-Jang, Shahram, Glassy, Mark C., Ghafouri-Fard, Soudeh

Volltext

Advanced strategies of targeting circular RNAs as therapeutic approaches in colorectal cancer drug resistance von Hussen, Bashdar Mahmud, Abdullah, Snur Rasool, Mohammed, Abdulqahar Azizkhan, Rasul, Mohammed Fatih, Hussein, Ali M., Eslami, Solat, Glassy, Mark C., Taheri, Mohammad

Volltext

Brain‐derived neurotrophic factor downregulation in gastric cancer von Esfandi, Farbod, Bouraghi, Hamid, Glassy, Mark C, Taheri, Mohammad, Kahaei, Mir Salar, Kholghi Oskooei, Vahid, Ghafouri‐Fard, Soudeh

Volltext

Altered ANRIL Methylation in Epileptic Patients von Mirzajani, Sara, Ghafouri-Fard, Soudeh, Habibabadi, Jafar Mehvari, Glassy, Mark C, Sayad, Arezou, Taheri, Mohammad

Volltext

Antibody Phage Display: Overview of a Powerful Technology that Has Quickly Translated to the Clinic von Kotlan, Beatrix, Glassy, Mark C.

Volltext

Technical and Ethical Limitations in Making Human Monoclonal Antibodies (An Overview) von Glassy, Mark C., Gupta, Rishab

Volltext

Abstract 2553: Pritumumab, a natural human IgG antibody defines a tumor-associated biomarker useful in treating brain cancer patients von Glassy, Mark C., Gupta, Rishab

Volltext

The natural human IgG1 mAb Pritumumab targets cell surface expressed vimentin and inhibits tumor growth von Glassy, Mark C, Babic, Ivan, Mukthavaram, Rajesh, Jiang, Pengfei, Nomura, Natsuko, Glassy, Eric, Kesari, Santosh

Volltext

AlteredANRILMethylation in Epileptic Patients von Mirzajani, Sara, Ghafouri-Fard, Soudeh, Habibabadi, Jafar Mehvari, Glassy, Mark C., Sayad, Arezou, Taheri, Mohammad

Volltext

Requirements for human antibody cocktails for oncology von Glassy, Mark C, McKnight, Michael E

Volltext

Abstract 5611: Use of ecto-domain vimentin to target brain cancers von Babic, Ivan, Mukthavaram, Rajesh, Jiang, Pengfei, Glassy, Eric, Nomura, Natsuko, Pingle, Sandeep, Glassy, Mark C., Kesari, Santosh

Volltext

Abstract 2357: Therapeutic potential of the natural human IgG1k antibody pritumumab von Babic, Ivan, Mukthavaram, Rajesh, Nomura, Natsuko, Pingle, Sandeep, Glassy, Mark C., Kesari, Santosh

Volltext

The nature of an ideal therapeutic human antibody von Glassy, Mark C, Koda, Keiji

Volltext

Abstract 2658: GPEx® system to increase production of pritumumab in a CHO cell line von Bleck, Gregory T., Gupta, Rishab K., Kotlan, Beatrix, York, Dona, Glassy, Mark C.

Volltext

Immunoincompetence in cancer patients: assessment by in vitro stimulation tests and quantification of lymphocyte subpopulations von DILLMAN, R. O, KOZIOL, Z. A, ZAVANELLI, M. I, BEAUREGARD, J. C, HALIBURTON, B. L, GLASSY, M. C, ROYSTON, I

Volltext